Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Phase 1 Completed 26 enrolled UCB BIOSCIENCES, Inc.

Non-randomizedParallel-groupOpen-label

Summary

To investigate the repeated dose Pharmacokinetics (PK) of transdermally delivered Rotigotine in Japanese and Caucasian female and male healthy subjects.

Timeline

Start: 2002-12
Primary completion: 2003-03
Completion: 2003-03

Publications

Cawello W, Kim SR, Braun M, Elshoff JP, Masahiro T, Ikeda J, Funaki T. Pharmacokinetics, safety, and tolerability of rotigotine transdermal system in healthy Japanese and Caucasian subjects following multiple-dose administration. Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):353-62. doi: 10.1007/s13318-015-0273-6. Epub 2015 Mar 13.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rotigotine	Unknown	1 mg	Other
Subject	Rotigotine	Unknown	2 mg	Other
Subject	Rotigotine	Unknown	4 mg	Other

Indications

No indication recorded.